Figure 3. Concentrations of sHLA-G, in maximum U/ml prior to onset of BOS, in bronchoalveolar lavage fluid (BALF) (upper panels) and plasma (lower panels) in 38 subjects based categorized by grade A rejection status (RA, left panels) or by grade of lymphocytic bronchiolitis (LB, right panels).

*, P = 0.006 by Kruskal-Wallis test, †, P = 0.044 by Kruskal-Wallis test.